Laboratory Corporation of America HoldingsNYSE: LH

BURLINGTON, N.C. , July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024.

Abstracts offer insights into precision oncology diagnostics for triple-negative breast cancer, liquid biopsy and machine learning for tumor profiling BURLINGTON, N.C. , May 30, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will present several abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (May 31 – June 4, 2024).

Labcorp (LH) is off to a strong start for the year ahead with its impressive first quarter performance in 2024.

Labcorp exceeded Wall Street's expectations for first-quarter profit on Thursday, due to an increase in sales at its diagnostics business driven by a rising demand for specialty tests.

Labcorp announced on Wednesday that it will acquire the assets of Invitae Corp, which were auctioned off as part of a voluntary bankruptcy protection process. This comes after Invitae Corp, a genetic test maker, filed for bankruptcy a few months ago.

Labcorp (LH) has the ideal combination of factors that could result in better-than-expected earnings in its upcoming report. Be ready with the key expectations.

Labcorp (LH) has a strong track record of exceeding earnings expectations and is well positioned to outperform in its upcoming quarterly report.

At Zacks, we prioritize the established Zacks Rank system, which highlights earnings estimates and revisions to identify top-performing stocks. However, we also keep a close eye on current value, growth, and momentum trends to highlight strong investment choices.

Labcorp has been granted Emergency Use Authorization from the FDA for its Mpox PCR Test Home Collection Kit.